As cosmetic surgery clinics new open up, pent-up demand for beauty procedures is expected to boost growth in the year 2021.
Botulinum Toxin market will go from a -8.6% slump in 2020 to a speedy recovery of 4.7% in 2021.
Over the last few years, botulinum toxin injectables and other aesthetic injectables are gaining much greater social acceptance.
Pre-pandemic growth drivers that will gradually come into play will include the expanding range of therapeutic indications for Botulinum Toxin and the rising demand for non-invasive cosmetic treatment solutions.
The market for long has been characterized by huge unmet medical needs and the ensuing strong off-label aesthetic and therapeutic uses of botulinum toxin.